The Australian market has experienced a mixed performance recently, with the ASX200 closing down 0.42% as big banks faced sell-offs while mining stocks provided some balance. Amid these fluctuations, investors may find opportunities in penny stocks, a term that still holds relevance despite its old-fashioned connotations. These smaller or newer companies can offer significant growth potential when supported by solid financials, presenting an intriguing option for those looking to uncover value beyond the mainstream market.
Name | Share Price | Market Cap | Financial Health Rating |
Embark Early Education (ASX:EVO) | A$0.775 | A$142.2M | ★★★★☆☆ |
LaserBond (ASX:LBL) | A$0.57 | A$66.82M | ★★★★★★ |
Austin Engineering (ASX:ANG) | A$0.535 | A$331.78M | ★★★★★☆ |
SHAPE Australia (ASX:SHA) | A$2.90 | A$240.44M | ★★★★★★ |
Vita Life Sciences (ASX:VLS) | A$1.94 | A$108.78M | ★★★★★★ |
Helloworld Travel (ASX:HLO) | A$1.98 | A$322.38M | ★★★★★★ |
MaxiPARTS (ASX:MXI) | A$1.90 | A$105.1M | ★★★★★★ |
SKS Technologies Group (ASX:SKS) | A$1.59 | A$253.28M | ★★★★★★ |
Big River Industries (ASX:BRI) | A$1.255 | A$107.15M | ★★★★★☆ |
Servcorp (ASX:SRV) | A$4.93 | A$486.42M | ★★★★☆☆ |
Click here to see the full list of 1,052 stocks from our ASX Penny Stocks screener.
Let's uncover some gems from our specialized screener.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Caravel Minerals Limited, with a market cap of A$108.70 million, explores for mineral tenements in Western Australia through its subsidiaries.
Operations: No revenue segments have been reported for Caravel Minerals.
Market Cap: A$108.7M
Caravel Minerals, with a market cap of A$108.70 million, is pre-revenue and currently unprofitable. Despite this, the company maintains a strong financial position with no debt and short-term assets of A$9.3 million exceeding liabilities of A$1.1 million. Recent capital raising efforts include an A$5 million equity offering, which supports its cash runway for over a year based on current free cash flow estimates. The management team is experienced with an average tenure of 5.3 years, although shareholders have faced dilution recently due to increased shares outstanding by 6.3%.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Delta Lithium Limited focuses on exploring and developing lithium and gold properties in Western Australia, with a market capitalization of A$136.14 million.
Operations: Delta Lithium Limited has not reported any specific revenue segments.
Market Cap: A$136.14M
Delta Lithium Limited, with a market capitalization of A$136.14 million, is pre-revenue and unprofitable, yet it maintains a debt-free status and has substantial short-term assets of A$89.8 million that comfortably cover its liabilities. The company has enough cash runway for over a year at current free cash flow levels but faces challenges with earnings expected to decline by an average of 24.1% annually over the next three years. Recent leadership changes include the resignation of Chairman Chris Ellison, succeeded by Nader El Sayed as Non-Executive Chairman, amidst an inexperienced board and management team with short tenures.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Harmoney Corp Limited operates in Australia and New Zealand, offering secured and unsecured personal loans online, with a market cap of A$41.81 million.
Operations: The company's revenue is derived from its Financial Services - Consumer segment, totaling A$35.42 million.
Market Cap: A$41.81M
Harmoney Corp Limited, with a market cap of A$41.81 million, operates in the financial services sector offering personal loans. Despite being unprofitable, it has reduced its losses by 12.6% annually over the past five years and maintains a positive free cash flow with a runway exceeding three years. The company boasts experienced leadership, with an average management tenure of 5.4 years and board members averaging 3.9 years. While short-term assets significantly surpass both short- and long-term liabilities, Harmoney's high net debt to equity ratio of over 1900% presents a risk factor for investors to consider carefully.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ASX:CVV ASX:DLI and ASX:HMY.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.